XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock and Additional Paid in Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Parent
Noncontrolling Interest
Common Stock Shares Outstanding
Total
Balance, beginning of period at Oct. 02, 2021 $ 6,339,506 $ (1,047,202) $ 40,690 $ (3,480,362)        
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021           $ 0    
Noncontrolling Interest in Joint Ventures at Jan. 01, 2022           0    
Number of shares, beginning of period at Oct. 02, 2021             108,734  
Number of shares, end of period at Jan. 01, 2022             109,518  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (46,198)            
Balance, end of period at Jan. 01, 2022 6,349,588 $ (1,116,025) 43,386 (3,424,185)        
Balance, beginning of period at Oct. 02, 2021 6,339,506 (1,047,202) 40,690 (3,480,362)        
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans 1,402              
Stock-based compensation expense 18,362              
Repurchases of treasury stock   $ (182,321)            
Other comprehensive income (loss)     10,165          
Net income attributable to common shareholders         $ 104,798     $ 104,798
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021           0    
Increase (Decrease) in Stockholders' Equity                
Net income attributable to noncontrolling interest               0
Number of shares, beginning of period at Oct. 02, 2021             108,734  
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans             1,177  
Number of shares, end of period at Apr. 02, 2022             109,911  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (4,697)            
Number of shares, end of period at Apr. 02, 2022   (49,124)            
Balance, end of period at Apr. 02, 2022 6,359,270 $ (1,229,523) 50,855 (3,375,564)        
Balance, beginning of period at Oct. 02, 2021 6,339,506 $ (1,047,202) 40,690 (3,480,362)        
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021           0    
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022           0    
Number of shares, beginning of period at Oct. 02, 2021             108,734  
Number of shares, end of period at Oct. 01, 2022             110,160  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (52,766)            
Balance, end of period at Oct. 01, 2022 6,381,348 $ (1,378,159) 56,325 (3,239,978)        
Balance, beginning of period at Jan. 01, 2022 6,349,588 (1,116,025) 43,386 (3,424,185)        
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans 352              
Stock-based compensation expense 9,330              
Repurchases of treasury stock   $ (113,498)            
Other comprehensive income (loss)     7,469          
Net income attributable to common shareholders         48,621     48,621
Noncontrolling Interest in Joint Ventures at Jan. 01, 2022           0    
Increase (Decrease) in Stockholders' Equity                
Net income attributable to noncontrolling interest               0
Number of shares, beginning of period at Jan. 01, 2022             109,518  
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans             393  
Number of shares, end of period at Apr. 02, 2022             109,911  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (2,926)            
Number of shares, end of period at Apr. 02, 2022   (49,124)            
Balance, end of period at Apr. 02, 2022 6,359,270 $ (1,229,523) 50,855 (3,375,564)        
Increase (Decrease) in Stockholders' Equity                
Total stockholders' equity               1,805,038
Total stockholders' equity               1,819,536
Balance, beginning of period at Oct. 01, 2022 6,381,348 $ (1,378,159) 56,325 (3,239,978)        
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022           0    
Noncontrolling Interest in Joint Ventures at Dec. 31, 2022           135,232    
Number of shares, beginning of period at Oct. 01, 2022             110,160  
Number of shares, end of period at Dec. 31, 2022             110,502  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (52,902)            
Balance, end of period at Dec. 31, 2022 6,471,299 $ (1,386,168) 63,275 (3,147,964)        
Balance, beginning of period at Oct. 01, 2022 6,381,348 (1,378,159) 56,325 (3,239,978)        
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans 295              
Stock-based compensation expense 24,143              
Sale of noncontrolling interest 78,169              
Repurchases of treasury stock   $ (21,507)            
Other comprehensive income (loss)     4,805          
Net income attributable to common shareholders         171,635     171,635
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022           0    
Increase (Decrease) in Stockholders' Equity                
Sale of noncontrolling interest           132,132    
Net income attributable to noncontrolling interest           8,786   8,786
Noncontrolling Interest in Joint Ventures at Apr. 01, 2023           140,918    
Number of shares, beginning of period at Oct. 01, 2022             110,160  
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans             1,125  
Number of shares, end of period at Apr. 01, 2023             111,285  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (361)            
Number of shares, end of period at Apr. 01, 2023   (53,127)            
Balance, end of period at Apr. 01, 2023 6,483,955 $ (1,399,666) 61,130 (3,068,343)        
Balance, beginning of period at Dec. 31, 2022 6,471,299 (1,386,168) 63,275 (3,147,964)        
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans 122              
Stock-based compensation expense 12,534              
Repurchases of treasury stock   $ (13,498)            
Other comprehensive income (loss)     (2,145)          
Net income attributable to common shareholders         $ 79,621     79,621
Noncontrolling Interest in Joint Ventures at Dec. 31, 2022           135,232    
Increase (Decrease) in Stockholders' Equity                
Net income attributable to noncontrolling interest           5,686   5,686
Noncontrolling Interest in Joint Ventures at Apr. 01, 2023           $ 140,918    
Number of shares, beginning of period at Dec. 31, 2022             110,502  
Increase (Decrease) in Stockholders' Equity                
Issuances under stock plans             783  
Number of shares, end of period at Apr. 01, 2023             111,285  
Increase (Decrease) in Stockholders' Equity                
Repurchases of treasury stock   (225)            
Number of shares, end of period at Apr. 01, 2023   (53,127)            
Balance, end of period at Apr. 01, 2023 $ 6,483,955 $ (1,399,666) $ 61,130 $ (3,068,343)        
Increase (Decrease) in Stockholders' Equity                
Total stockholders' equity               $ 2,217,994